NDC 0143-9262-01 - Cefazolin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9262
- Requested NDC
- 0143-9262-01
- Package NDCs from labels
- 0143-9262-01, 0143-9262-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2026-05-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CEFAZOLIN FOR INJECTION, USP | Hikma Pharmaceuticals USA Inc. | 2026-05-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9262-01 | Cefazolin | 3 mL in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 3 | 7 | |
| 0143-9262-25 | Cefazolin | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9262-01 | EA - Each | 0143-9262 | 46a85f09-be04-4546-b32f-1e2fa7116617 | 1 | 2017-08-11 |
| 0143-9262-25 | EA - Each | 0143-9262 | 219f6c19-800c-4f89-bb54-e27de2cbb333 | 1 | 2017-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefazolin | CEFAZOLIN | Apotex Corp. | 37a626aa-96dc-4c4d-bfbc-be4f328f918b | 2023-12-15 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | Apotex Corp. | 0e8d4462-7642-4296-a605-6c1493e91ffd | 2023-12-14 | Warnings, Adverse reactions | P380M0454Z |
| Cefazolin | CEFAZOLIN | Apotex Corp. | 81d1783a-2baa-4d65-856a-f5ce38d24804 | 2023-12-14 | Warnings, Adverse reactions | P380M0454Z |
| CEFAZOLIN | CEFAZOLIN SODIUM | Fresenius Kabi USA, LLC | c47c8d14-1eef-40f9-9d11-f0c300b1d4be | 2023-09-27 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | A-S Medication Solutions | 8a772acc-726d-40e6-88ee-b6075cbf9b28 | 2023-06-23 | Warnings, Adverse reactions | ANDA065047 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | Medical Purchasing Solutions, LLC | 6673be13-4c74-70b9-e053-2a91aa0a211d | 2023-06-01 | Warnings, Adverse reactions | ANDA065047 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | Medical Purchasing Solutions, LLC | 79787707-c84f-f229-e053-2a91aa0a1f16 | 2023-05-16 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | Proficient Rx LP | d24529e3-e2b4-46d6-81ba-b7da74501792 | 2022-08-01 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | Sandoz Inc | e58f87fb-a47d-4081-a454-e4e916e2f629 | 2020-09-08 | Warnings, Adverse reactions | P380M0454Z |
| Cefazolin | CEFAZOLIN SODIUM | Fresenius Kabi USA, LLC | 47a8928f-708d-418a-829b-36eded96bac0 | 2020-06-17 | Boxed warning, Warnings, Adverse reactions | P380M0454Z |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.